Abstract
Purpose
Management of choroidal metastases is commonly with systemic chemotherapy; however, if tumours are refractory to treatment and vision is endangered, local therapy modalities are feasible. A novel option is the use of intravitreal bevacizumab. This report presents three cases of choroidal metastatic tumours secondary to lung and breast cancer treated with intravitreal bevazizumab.
Patients and methods
Three patients with choroidal metastases secondary to lung and breast tumours were treated at the Ophthalmology Unit, University of Rome ‘Sapienza’, S.Andrea Hospital from January 2009 to August 2012. All patients developed vision loss with diagnosis of chorioidal metastasis during systemic chemotherapy. Off label intravitreal bevacizumab treatment was performed with two 1.25 mg injections in two patients and four injections in one patient at 30-day intervals.
Results
Vision improved, subretinal fluid resolved, and choroidal tumour regression was obtained in all cases. Follow-up was 6, 9, and 12 months and there were no complications related to treatment.
Conclusions
Intravitreal bevacizumab administration represented an efficacious therapeutic option with rapid effect in the treatment of choroidal metastatic tumours unresponsive to systemic therapy. It can have a role in the management of these tumours by preventing vision loss and improving the quality of life of patients.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Bloch RS, Gartner S . The incidence of ocular metastatic carcinoma. Arch Ophthalmol 1971; 85: 673–675.
Camarillo C, Sànchez Ronco I, Encinas JL . Choroidal metastases. An Sist Sanit Navar 2008; 31 (Suppl 3): 127–134.
Shields CL, Shields JA, Gross N, Schwartz GP, Lally SE . Survey of 520 eyes with uveal metastases. Ophthalmology 1997; 104: 1265–1276.
Chen CJ, McCoy AN, Brahmer J, Handa JT . Emerging treatments for choroidal metastases. Surv Ophthalml 2011; 56 (6): 511–521.
Kaliki S, Shields CL, Al-Damash SA, Mashayekhi A, Shields JA . Photodynamic therapy for choroidal metastasis in 8 cases. Ophthalmology 2012; 119 (6): 1218–1222.
Giantonio BJ, Catalano PJ, Meropol NJ, O’Dwyer PJ, Mitchell EP, Alberts SR et al. Eastern Cooperative Oncology Group Study E3200. Bevacizumab in combination with oxalilplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 2007; 25 (12): 1539–1544.
George B, Wirostko WJ, Conner TB, Choong NW . Complete and durable response of choroidal metastasis from non-small cell lung cancer with systemic bevacizumab and chemotherapy. J Thorac Oncol 2009; 4: 661–662.
D’Antonio C, Viterbo A, Romiti A, Maurizi Enrici M, Lauro S, Marchetti P . Complete regression of a non-small cell lung cancer choroidal metastasis with intravitreal bevacizumab. J Thorac Oncol 2012; 7: 468–469.
Lai CL, Fan KS, Lee YH, Chen HC, Fan WH . Intravitreal administration of bevacizumab in the treatment of choroidal metastasis in a patient with erlotinib-failed pulmonary adenocarcinoma. Lung Cancer 76 2012; 496–498.
Amselem L, Cervera E, Diaz-Llopis M, Montero J, Garcia-Pous M, Udaondo P et al. Intravitreal bevacizumab (Avastin) for choroidal mestastasis secondary to breast carcinoma: short-term follow-up. Eye (Lond) 2007; 21 (4): 556–557.
Yao HY, Horng CT, Chen JT, Tsai ML . Regression of choroidal metastasis secondary to breast carcinoma with adjuvant intravitreal injection of bevacizumab. Acta Ophthalmol 2010; 88 (7): 282–283.
Mansour AM, Alameddine R . Intravitreal bevacizumab for consecutive multiple choroidal breast metastatic lesions. BMJ Case Rep 2012 e-pub ahead of print 15 June 2012; doi:10.1136/bcr.03.2012.6124.
Rudoler SB, Corn BW, Shields CL, de Potter P, Hyslop T, Shields JA et al. External beam irradiation for choroid metastases: identification of factors predisposing to long-term sequelae. Int J Radiat Oncol Biol Phys 1997; 38 (2): 2516.
Shields CL, Shields JA, De Potter P, Quaranta M, Freire J, Brady LW et al. Plaque radiotherapy for the management of uveal metastasis. Arch Ophthalmol 1997; 115 (2): 203–209.
Kiratli H, Bilgic S . Transpupillary thermotherapy in the management of choroidal metastases. Eur J Ophthalmol 2004; 14 (5): 423–429.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Fenicia, V., Abdolrahimzadeh, S., Mannino, G. et al. Intravitreal bevacizumab in the successful management of choroidal metastases secondary to lung and breast cancer unresponsive to systemic therapy: a case series. Eye 28, 888–891 (2014). https://doi.org/10.1038/eye.2014.96
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2014.96
This article is cited by
-
Treatment response to intravitreal bevacizumab in small pigmented choroidal lesions with subretinal fluid
BMC Ophthalmology (2019)
-
Pigment dispersion syndrome and pigmentary glaucoma: a review and update
International Ophthalmology (2019)
-
Intravitreal bevacizumab for choroidal metastases: the key to efficacy is simultaneous administration of systemic therapy
Eye (2015)
-
Failure of intravitreal bevacizumab in the treatment of choroidal metastasis
Eye (2015)
